Revenues of SpringWorks Therapeutics, Inc. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: SpringWorks Therapeutics, Inc. annual and quarterly Revenues in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
SpringWorks Therapeutics, Inc. Revenues for the quarter ending 30 Sep 2024 was $49,301,000.
SpringWorks Therapeutics, Inc. annual Revenues for 2024 was $191,589,000, a 3417% increase from 2023.
SpringWorks Therapeutics, Inc. annual Revenues for 2023 was $5,447,000.
Source SEC data: View on sec.gov

Revenues, Annual (USD)

Revenues, YoY Annual Change (%)

Revenues, Quarterly (USD)

SpringWorks Therapeutics, Inc. Annual Revenues (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$191,589,000	+$186,142,000	+3417%	01 Jan 2024	31 Dec 2024	10-K	20 Feb 2025	2024	FY
2023	$5,447,000	+$5,447,000		01 Jan 2023	31 Dec 2023	10-K	20 Feb 2025	2024	FY
2022	$0			01 Jan 2022	31 Dec 2022	10-K	20 Feb 2025	2024	FY

Period	Value	YoY Chg	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$49,301,000	+$49,301,000	01 Jul 2024	30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$59,733,000	+$59,733,000	01 Apr 2024	30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q3 2023	$0		01 Jul 2023	30 Sep 2023	10-Q	12 Nov 2024	2024	Q3
Q2 2023	$0		01 Apr 2023	30 Jun 2023	10-Q	07 Aug 2024	2024	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.